SBC Medical Group (SBCWW) Financials: Revenue & Earnings

SBCWW price $0.47 +0.03 +6.80%

Ticker
SBCWW
Price
$0.47
Change
+0.03 +6.80%
Market cap ?
$48.33M
Beta ?
0.59
Sector
Industrials
Industry
Specialty Business Services

Fair value

SBCWW fair value $17.23. Price $0.47. Price is 97% below fair value.

Below fair value, but more expensive than usual. A smaller discount than on 87% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 75.34M. Growth 10.01%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 102.85M. Net debt -112.14M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare SBCWW

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-13—0.12—48.90M
2026-08-130.100.1249.19M45.37M
2026-05-140.110.1043.06M41.66M
2026-03-270.140.1239.57M45.44M
2025-11-140.120.1143.35M45.18M
2025-08-130.020.1443.36M44.71M
2025-05-150.210.1547.33M57.55M
2025-03-280.060.1744.00M56.85M
2024-11-130.032.3653.08M54.70M
2024-08-160.202.3653.00M54.70M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
No data yet.

Institutional holders

HolderSharesChangeChange %Value
No data yet.

Earnings and financials

SBC Medical Group Holdings Incorporated (SBCWW) trades at $0.47, with a market cap of $48.33M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

SBC Medical Group (SBCWW) Financials: Revenue & Earnings

SBCWW$0.47+0.03 +6.80%

$48.33M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History